Tobevibart and elebsiran for the treatment of chronic hepatitis delta.

Saved in:
Bibliographic Details
Title: Tobevibart and elebsiran for the treatment of chronic hepatitis delta.
Authors: Sandmann L; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany; German Center for Infection Research (DZIF), Hannover/Braunschweig, Germany. Electronic address: sandmann.lisa@mh-hannover.de.
Source: Journal of hepatology [J Hepatol] 2026 Mar; Vol. 84 (3), pp. 677-678. Date of Electronic Publication: 2026 Jan 19.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1600-0641
DOI:10.1016/j.jhep.2025.12.018